Background: Pancytopenia is a frequently encountered hematological problem in clinical practice. Objective: Evaluate the haematological parameters including bone marrow aspiration /marrow biopsy. Methods: This observational study was conducted among patients admitted in the Department of Medicine in K R hospital Mysuru, Karnataka Definition of study subject; Adult male and female with pancytopenia. Study period was 18 months (From January 2019 to june 2020). Ethical clearance was taken from the institutional ethical committee. Results: Lowest hemoglobin percentage was 2.6 g/dl and noted in case of megaloblastic anemia. Lowest total leucocyte count was 500 cells per cubic mm. Lowest platelet count is 8000 cells per cubic mm. Hypercellular marrow was noted in 26 cases and hypocellular marrow noted in 7 cases. normocellular marrow in 2 cases. Conclusions: The physical findings, peripheral blood picture and bone marrow evaluation provides valuable information. Bone marrow examination is accurate, reproducible, rapidly available information at an economical cost and with minimal discomfort to the patient.
Pancytopenia is a condition where the formed elements of blood i.e RBC,WBC,PLATELETS are lower than the normal reference range. pancytopenia is a triad of anemia, leukopeniaand thrombocytopenia. various conditions which directly or indirectly involve bone marrow manifest as pancytopenia. etiology of pancytopenia ranges from simple drug induced bone marrow hypoplasia, deficiency like vit B12, folic acid to life threatening leukemias. To know the exact etiology of pancytopenia is atmost important for the therupetic purpose and prognosis.
Sir William Harvey described blood as ‘fountain of life and the primary seat of soul. The marrow in our bones is the seedbed of our blood1. examination of bone marrow is critically important in study and management of wide variety of hematological disorders. spectrum of disorders primarily or secondarly affecting bone marrow may manifest as pheripheral pancytopenia2 .pancytopenia is disorder in which all three major formed elements in blood (RBC,WBC,PLATALETS) are below the normal reference range3 .presenting symptom is often attributed to anemia/thrombocytopenia. leukopenia is an uncommon cause of initial presentation but can become the most serious threat to life during the course of disorder4,5. pancytoenia is serious hematological problem, the underlyning cause of which is diagnosed by bonemarrow examination. underlyning pathology determines the management and prognosis of patients ,hence its extremely important to study the etiology of pancytopenia.
This observational study was conducted among patients admitted in the Department of Medicine in K R hospital Mysuru,Karnataka Definition of study subject; Adult male and female with pancytopenia. Study period was 18 months (From January 2019 to june 2020). Ethical clearance was taken from the institutional ethical committee
Secondary source of information from published articles, journals, books, case sheets, discharge summary, related websites were used in planning, developing synopsis and during dissertation as supporting document.
METHODS OF COLLECTION OF DATA
Sample Size:
Sample size calculated is 35 with level of confidence as 5% and absolute allowable error as 5% with prevalence of pancytopenia being 2% using confidence interval technique.
Inclusion criteria:
All the cases of pancytopenia with Haemoglobin less than 10gm/dl, White blood cell count less than 4000 cells/cumm and platelet count less than 1,50,000 cells/cumm admitted in K R hospital ,Mysuru.
Exclusion criteria:
The study requires following investigations
DATA ANALYSIS:
Total 35 patients aged between 19 to 81 years age group presenting with pancytopenia are evaluated. Combined evaluation of physical findings, primary hematological investigation and bone marrow examination were done in all patients. Commonest age group affected is 31-40 years. Males accounted for 19 cases (54%), females 16 cases (46%).
TABLE- 1 -VITAL HEMATOLOGICAL PARAMETERS
SL NO |
PARAMETERS |
RANGE |
NO OF CASES |
PERCENTAGE |
1 |
HAEMOGLOBIN(g%) |
1.8-5 |
14 |
40 |
|
|
5-8 |
17 |
48.57 |
|
|
8-10 |
04 |
11.43 |
2 |
TOTAL LEUCOCYTE COUNT(cells/cumm) |
500-1000 |
04 |
11.43 |
|
|
1001-2500 |
21 |
60 |
|
|
2501-4000 |
10 |
28.57 |
3 |
PLATELET COUNT(cells/cumm) |
2000-10000 |
02 |
5.71 |
|
|
10000-50000 |
24 |
68.57 |
|
|
50000-100000 |
09 |
25.71 |
FIGURE- 08 - VITAL HAEMATOLOGICAL PARAMETERS, HAEMOGLOBIN
FIGURE- 02 -VITAL HAEMATOLOGICAL PARAMETERS,TLC
FIGURE- 3 -VITAL HAEMATOLOGICAL PARAMETERS,PLATELET
Lowest hemoglobin percentage was 2.6 g/dl and noted in case of megaloblastic anemia. Lowest total leucocyte count was 500 cells per cubic mm. Lowest platelet count is 8000 cells per cubic mm Hypercellular marrow was noted in 26 cases and hypocellular marrow noted in 7 cases.normocellular marrow in 2 cases.
TABLE- 2 -PERIPHERAL BLOOD SMEAR IN PANCYTOPENIA
SL NO |
PERIPHERAL BLOOD SMEAR |
NO OF CASES |
PERCENTAGE |
1 |
Macrocytic |
19 |
54.29 |
2 |
Normocytic |
09 |
25.70 |
3 |
Dimorphic |
04 |
11.43 |
4 |
microcytic |
03 |
8.56 |
|
total |
35 |
100 |
FIGURE- 4 -PERIPHERAL BLOOD SMEAR IN PANCYTOPENIA
Most common peripheral blood finding is macrocytic picture(54.29%) and least common is microcytic picture(8.56 %)
TABLE-3 -BONE MARROW CELLULARITY
SL NO |
BONE MARROW |
NO OF CASES |
PERCENTAGE |
1 |
Hypercellular |
26 |
74.29 |
2 |
Hypocellular |
07 |
20 |
3 |
Normocellular |
02 |
5.71 |
|
total |
35 |
100 |
FIGURE-4 -BONE MARROW CELLULARITY
Most common is hypercellular(74.29%) and least common is normocellular(5.71%).
Pancytopenia is commonly seen in various clinical settings all over the world. Total 35 cases of pancytopenia were studied from Jan 2019 to Jun 2020 at KR hospital, Mysuru.
FIGURE -5- comparison of haemoglobin values between our study and study done by gayathri et al in megaloblastic group.
FIGURE-6-Comparison of WBC values between our study and study done by gayathri et al
FIGURE -7 - comparison of platelet values with our study and study done by gayathri et al in megaloblastic group.
The findings of above study also indicates the prompt identification of patients with megaloblastic anemia and treating the underlyning cause in initial stage itself can reduce the incidence of pancytopenia and its various complications.
Indian J Pathol Microbiol 1992;42(4):399-404.